AU2001267242A1 - Grf2-binding proteins and applications thereof - Google Patents

Grf2-binding proteins and applications thereof

Info

Publication number
AU2001267242A1
AU2001267242A1 AU2001267242A AU6724201A AU2001267242A1 AU 2001267242 A1 AU2001267242 A1 AU 2001267242A1 AU 2001267242 A AU2001267242 A AU 2001267242A AU 6724201 A AU6724201 A AU 6724201A AU 2001267242 A1 AU2001267242 A1 AU 2001267242A1
Authority
AU
Australia
Prior art keywords
protein
cell
grf2
proteins
interacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267242A
Other languages
English (en)
Inventor
Linda Mcbroom
Michael F. Moran
Olga Ornatzsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MDS Proteomics Inc
Original Assignee
MDS Proteomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MDS Proteomics Inc filed Critical MDS Proteomics Inc
Publication of AU2001267242A1 publication Critical patent/AU2001267242A1/en
Assigned to MDS PROTEOMICS INC. reassignment MDS PROTEOMICS INC. Amend patent request/document other than specification (104) Assignors: MDS PROTEOMICS, INC.
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
AU2001267242A 2000-06-30 2001-06-29 Grf2-binding proteins and applications thereof Abandoned AU2001267242A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21550400P 2000-06-30 2000-06-30
US60/215,504 2000-06-30
US26369001P 2001-01-24 2001-01-24
US60/263,690 2001-01-24
PCT/CA2001/000941 WO2002002629A2 (en) 2000-06-30 2001-06-29 Grf2-binding proteins and applications thereof

Publications (1)

Publication Number Publication Date
AU2001267242A1 true AU2001267242A1 (en) 2002-01-14

Family

ID=26910105

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267242A Abandoned AU2001267242A1 (en) 2000-06-30 2001-06-29 Grf2-binding proteins and applications thereof

Country Status (7)

Country Link
US (1) US20040170969A1 (ja)
EP (1) EP1299534A2 (ja)
JP (1) JP2004501670A (ja)
AU (1) AU2001267242A1 (ja)
CA (1) CA2413715A1 (ja)
IL (1) IL153740A0 (ja)
WO (1) WO2002002629A2 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6933127B2 (en) 2001-07-05 2005-08-23 Eucro European Contract Research Gmbh & Co. Kg Substrate for PP2C
JP2004018524A (ja) * 2002-06-13 2004-01-22 Eucro European Contract Research Gmbh & Co Kg 動脈硬化症を処置するための方法
EP1717320A1 (en) * 2005-04-26 2006-11-02 TopoTarget Germany AG Identification of human gene sequences of cancer antigens expressed in metastatic carcinoma and involved in metastasis formation, and their use in cancer diagnosis, prognosis and therapy
WO2019158911A1 (en) * 2018-02-14 2019-08-22 Institute Of Genetics And Developmental Biology Chinese Academy Of Sciences Methods of increasing nutrient use efficiency

Also Published As

Publication number Publication date
US20040170969A1 (en) 2004-09-02
EP1299534A2 (en) 2003-04-09
JP2004501670A (ja) 2004-01-22
WO2002002629A3 (en) 2002-09-06
CA2413715A1 (en) 2002-01-10
WO2002002629A2 (en) 2002-01-10
IL153740A0 (en) 2003-07-06

Similar Documents

Publication Publication Date Title
Martincic et al. Isolation and characterization of a dual prenylated Rab and VAMP2 receptor
Alto et al. Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics
Yan et al. A complex of two centrosomal proteins, CAP350 and FOP, cooperates with EB1 in microtubule anchoring
Bosc et al. Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2
US7252968B2 (en) Chromatin regulator genes
Bustelo et al. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation
US20040166530A1 (en) F-box proteins and genes
Llorian et al. SIPP1, a novel pre-mRNA splicing factor and interactor of protein phosphatase-1
WO1995033819A2 (en) Cdk4 (cyclin dependent kinase 4) binding proteins
Vivo et al. The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein
US5821082A (en) Anti-proliferation domain of a human Bcl-2 and DNA encoding the same
US6503742B1 (en) Ubiquitin ligases and uses related thereto
Dobrosotskaya Identification of mNET1 as a candidate ligand for the first PDZ domain of MAGI-1
LIN et al. Mitogen-stimulated TIS21 protein interacts with a protein-kinase-Cα-binding protein rPICK1
US20040170969A1 (en) GRF2 binding proteins and applications thereof
AU9223198A (en) Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods
US6747128B2 (en) Components of ubiquitin ligase complexes, and uses related thereto
WO1996039527A1 (en) Cell-cycle regulatory proteins from human pathogens, and uses related thereto
US20070249814A1 (en) Transcriptional regulatory factor
US20020143164A1 (en) Ras activator nucleic acid molecules, polypeptides and methods of use
US20030077288A1 (en) Compositions and methods for treatment of muscle wasting
US20030104362A1 (en) Cell-cycle regulatory proteins from human pathogens, and uses related thereto
AU4056900A (en) Isolated DNA encoding cullin regulators ROC1 and ROC2, isolated proteins encoded by the same, and methods utilizing the same
US7193051B2 (en) Histidine phosphatase interacting protein with 240kD
US7402394B2 (en) Centrosome-associated protein and applications thereof

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application